Redrobe J P, MacSweeney C P, Bourin M
Department of Pharmacology, Faculty of Medecine, Nantes, France.
Eur J Pharmacol. 1996 Dec 30;318(2-3):213-20. doi: 10.1016/s0014-2999(96)00772-8.
The forced swimming test is a behavioural model developed to predict the efficacy of antidepressant drugs. Few studies have been aimed at evaluating the mechanism of action of antidepressants in the forced swimming test. The present study was designed in order to further evaluate the mode of action of antidepressants in the forced swimming test, by using selective agonists and antagonists at 5-HT1A and 5-HT1B receptor sites. Agonists/antagonists and antidepressants were administered 45 min and 30 min, respectively, prior to testing. Prior administration of 8-hydroxy-2-(di-n-propylamino)tetralin (8-OH-DPAT) (1 mg/kg, i.p.) induced anti-immobility effects with the tricyclic antidepressant imipramine (8 mg/kg, i.p.) and noradrenaline uptake inhibitors maprotiline (8 mg/kg, i.p.) and desipramine (16 mg/kg, i.p.), but not with fluoxetine (16 mg/kg, i.p.), citalopram (16 mg/kg, i.p.) or fluvoxamine (8 mg/kg, i.p.). These effects were antagonised by prior administration of 1-(2-methoxyphenyl)-4-[-(2-phthalimido)butyl]piperazine) (NAN 190) (0.5 mg/kg, i.p.). On the other hand, pretreatment with (+/-)-pindolol (32 mg/kg, i.p.) potentiated the effects of the selective serotonin reuptake inhibitors and was devoid of any activity with imipramine (8 mg/kg, i.p.), maprotiline (8 mg/kg, i.p.) or desipramine (16 mg/kg, i.p.). Prior administration of 5-methoxy-3-(1,2,3,6-tetrahydro-4-pyridyl)-1H-indole (RU 24969) enhanced the antidepressant-like effects of the selective serotonin reuptake inhibitors and imipramine (8 mg/kg, i.p.) in the forced swimming test. The anti-immobility effects of the selective serotonin reuptake inhibitors in the forced swimming test seem to be mediated by presynaptic 5-HT1A receptors as well as postsynaptic 5-HT1B receptors. Antidepressant-like effects of the noradrenaline uptake inhibitors seem, on the other hand, to be mediated by postsynaptic 5-HT1A receptors. Considering the variety of 5-HT receptors, it is possible that other subtypes may participate in the anti-immobility effects of antidepressants in the forced swimming test.
强迫游泳试验是一种用于预测抗抑郁药物疗效的行为学模型。很少有研究旨在评估抗抑郁药在强迫游泳试验中的作用机制。本研究旨在通过使用5-HT1A和5-HT1B受体位点的选择性激动剂和拮抗剂,进一步评估抗抑郁药在强迫游泳试验中的作用方式。激动剂/拮抗剂和抗抑郁药分别在测试前45分钟和30分钟给药。预先给予8-羟基-2-(二正丙基氨基)四氢萘(8-OH-DPAT)(1毫克/千克,腹腔注射)可诱导产生抗不动效应,与三环类抗抑郁药丙咪嗪(8毫克/千克,腹腔注射)、去甲肾上腺素摄取抑制剂马普替林(8毫克/千克,腹腔注射)和地昔帕明(16毫克/千克,腹腔注射)联合使用时有效,但与氟西汀(16毫克/千克,腹腔注射)、西酞普兰(16毫克/千克,腹腔注射)或氟伏沙明(8毫克/千克,腹腔注射)联合使用时无效。这些效应可被预先给予的1-(2-甲氧基苯基)-4-[(2-邻苯二甲酰亚胺基)丁基]哌嗪(NAN 190)(0.5毫克/千克,腹腔注射)拮抗。另一方面,预先给予(±)-吲哚洛尔(32毫克/千克,腹腔注射)可增强选择性5-羟色胺再摄取抑制剂的效应,而对丙咪嗪(8毫克/千克,腹腔注射)、马普替林(8毫克/千克,腹腔注射)或地昔帕明(16毫克/千克,腹腔注射)无任何作用。预先给予5-甲氧基-3-(1,2,3,6-四氢-4-吡啶基)-1H-吲哚(RU 24969)可增强选择性5-羟色胺再摄取抑制剂和丙咪嗪(8毫克/千克,腹腔注射)在强迫游泳试验中的抗抑郁样效应。选择性5-羟色胺再摄取抑制剂在强迫游泳试验中的抗不动效应似乎是由突触前5-HT1A受体以及突触后5-HT1B受体介导的。另一方面,去甲肾上腺素摄取抑制剂的抗抑郁样效应似乎是由突触后5-HT1A受体介导的。考虑到5-羟色胺受体的多样性,其他亚型可能参与抗抑郁药在强迫游泳试验中的抗不动效应。